Home

Innate immune response and Th1 inflammation

Introduction

The innate immune response is the body's first line of defense against and a non-specific way for responding to bacterial pathogens.1) Located in the nucleus of a variety of cells, the Vitamin D nuclear receptorA nuclear receptor located throughout the body that plays a key role in the innate immune response. (VDR) plays a crucial, often under-appreciated, role in the innate immune response. The vitamin D receptor and T cell function

When functioning properly, the VDR transcribes between hundreds2) and thousands of genes3) including those for the proteins known as the antimicrobial peptides. Antimicrobial peptides are “the body's natural antibiotics,” crucial for both prevention and clearance of infection.4) The VDR also expresses the TLR2A receptor which is expressed on the surface of certain cells and recognizes native or foreign substances and passes on appropriate signals to the cell and/or the nervous system. receptor, which is expressed on the surface of certain cells and recognizes foreign substances.

The body controls activity of the VDR through regulation of the vitamin D metabolites. 25-hydroxyvitamin D (25-DThe vitamin D metabolite widely (and erroneously) considered best indicator of vitamin D "deficiency." Inactivates the Vitamin D Nuclear Receptor. Produced by hydroxylation of vitamin D3 in the liver.) antagonizes or inactivates the Receptor while 1,25-dihydroxyvitamin DPrimary biologically active vitamin D hormone. Activates the vitamin D nuclear receptor. Produced by hydroxylation of 25-D. Also known as 1,25-dihydroxycholecalciferol, 1,25-hydroxyvitamin D and calcitirol. (1,25-DPrimary biologically active vitamin D hormone. Activates the vitamin D nuclear receptor. Produced by hydroxylation of 25-D. Also known as 1,25-dihydroxycholecalciferol, 1,25-hydroxyvitamin D and calcitirol.) agonizes or activates the Receptor.

Greater than 36 types of tissue have been identified as having a Vitamin D Receptor.5)

Another component of the innate immune response is the release of inflammatory cytokines. The result is what medicine calls inflammation, which generally leads to an increase in symptoms.

Adenosine: an endogenous regulator of innate immunity. 6)

Before the Human MicrobiomeThe bacterial community in the human body. Many species in the microbiota contribute to the development of chronic disease. Project, scientists couldn't link bacteria to inflammatory diseases. But with the advent of DNA sequencing technology, scientists have detected many of the bacteria capable of generating an inflammatory response. All diseases of unknown etiology are inflammatory diseases.

Critical illness is a complex life-threatening disease characterized by profound endocrine and metabolic alterations and by a dysregulated immune response, together contributing to the susceptibility for nosocomial infections and sepsis

Hyperglycaemia, as part of the endocrine-metabolic responses to stress, is present in virtually all critically ill patients and is associated with poor outcome.

Not using parenteral nutrition during the first week in intensive care units, and so accepting a large macronutrient deficit, also resulted in fewer secondary infections, less weakness and accelerated recovery.

The human body: how we fail how we heal

Research

Those with a high intellectual capacity (hyper brain) possess overexcitabilities in various domains that may predispose them to certain psychological disorders as well as physiological conditions involving elevated sensory, and altered immune and inflammatory responses (hyper body). Science Direct

Modern vaccinations, fear of germs and obsession with hygiene are depriving the immune system of the information input upon which it is dependent. ….and may lead to increased incidences of allergies and autoimmune diseases. 7)

Country kids had more, and more-diverse, bacteria on their skin, with a particularly high abundance of Acinetobacter—a genus of microbes in the Proteobacteria phylum that are commonly found on plants. The researchers further found that children with more Acinetobacter on their skin had more leukocytes in their bloodstream and that these cells were much more capable of producing the anti-inflammatory cytokine IL-10 compared with the leukocytes of urban kids. influence of soil on human health

Insulin gives an extra boost to the immune system 8)

Results indicate a relationship between muscular TLR4, p-AMPK and NF-κB content and insulin sensitivity. The study also highlights that in situations of insulin resistance, such as in diabetic subjects, metformin treatment may prevent attenuation of activation of the inflammatory pathway. 9)

Glucose homeostasis, nutrition and infections during critical illness 10)

Adenosine is an important molecule that exerts control on the immune system, by signaling through receptors lying on the surface of immune cells. 11)

An exciting area of recent investigation has arisen from the discovery that SCFA play a role in regulating the immune system and inflammatory response. Early work at the turn of this century had demonstrated the potential role of butyrate in immune regulation when it was shown that butyrate inhibits nuclear factor kappa β (NF-κΒ) activation in macrophages and also inhibits histone deacetylation (HDAc) in acute myeloid leukemia.

Whether SCFA act as a signal to induce tolerance to the host-associated microbiome or directly reduce inflammatory responses remains to be fully elucidated. SCFA do appear able to reduce the responsiveness of lamina propria macrophages to commensal bacteria, via nitric oxide, IL-6, and IL-12 independent of FFAR signaling, to induce tolerance.

Recent data also suggests butyrate suppresses TNF-α, IL-6, and myeloperoxidase activity by preventing NF-κΒ activation in Kupffer cells.12)

Nuclear receptors and ligands

Nuclear receptorsIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affect transcription. are a class of proteins found within the interior of cells that are responsible for sensing the presence of hormones and certain other molecules. A unique property of nuclear receptors which differentiate them from other classes of receptors is their ability to directly interact with and control the expression of genomic DNA. Some of the molecules (or ligands) which bind the nuclear receptor activate (agonize) it and some inactivate (antagonize) it.

It is commonly accepted that most ligands, approximately 95% to 98%, inactivate the nuclear receptors. Since the nuclear receptors play a significant role in the immune response, this factor alone may explain why so many drugs and substances found in food and drink are immunosuppressive.

Because the expression of a large number of genes is regulated by nuclear receptors, ligands that activate these receptors can have profound effects on the organism. Many of these regulated genes are associated with various diseases which explains why the molecular targets of approximately 13% of FDA approved drugs are nuclear receptors.13)

Different cell types have different nuclear receptors. One of the nuclear receptors seen in immune cells is the Vitamin D Receptor (VDR). The VDR has two endogenous or “native” ligands, which are also the two main forms of vitamin D in the human body: 25-hydroxyvitamin D (25-D) and 1,25-dihydroxyvitamin D (1,25-D). Non-native or exogenous ligands can also inactivate or activate a nuclear receptor, depending on its molecular structure.

Ligands compete to dock at nuclear receptors. When is a given kind of ligand such as 25-D as opposed to 1,25-D more likely to bind to the VDR? It depends. 1,25-D tends to be much less common than 25-D – by a factor of 1,000 or more – so it binds to the receptor much more infrequently. A greater concentration of a given molecule can displace competing molecules off the nuclear receptor. Affinity occurs in logarithmic fashion, which is to say that it operates on the basis of a sliding scale. In short, an increase in 1,25-D and a decrease in 25-D can tilt the odds in favor of 1,25-D, and vice versa.

Affinity as well as the question of whether a ligand inactivates or activates a nuclear receptor can all be validated using in silicoExperiment technique performed on computer or via computer emulation. modeling. Although less precise, it is also possible to measure these properties in vitro.

Activated by 1,25-D and inactivated by 25-D, the Vitamin D nuclear receptor (VDR) transcribes a number of genes crucial to the function of the innate immune response.

Role of Vitamin D Receptor in innate immunity

Vitamin D/VDR have multiple critical functions in regulating the response to intestinal homeostasis, tight junctions, pathogen invasion, commensal bacterial colonization, antimicrobe peptide secretion, and mucosal defense…. The involvement of Vitamin D/VDR in anti-inflammation and anti-infection represents a newly identified and highly significant activity for VDR.

Jun Sun 14)

When activated by 1,25-D, the Vitamin D Receptor (also called the calcitriol receptor) transcribes thousands of genes.15) It is commonly known that the VDR functions in regulating calcium metabolism.16) It is becoming increasingly clear, however, that the clinically accepted role of the Vitamin D metabolites, that of regulating calcium homeostasis, is just a small subset of the functions actually performed by these hormones.

Transcription of antimicrobial peptides

One of the VDR's key functions is the transcription of antimicrobial peptides.17) 18) See below.

Other antimicrobial activity of the VDR

Additionally, when the VDR is activated, TLR2 is expressed.19) TLR2 is a receptor, which is expressed on the surface of certain cells and recognizes native or foreign substances, and passes on appropriate signals to the cell and/or the nervous system.

When activated TLR2 allows the immune system to recognize gram-positive bacteria, including Staphylococcus aureus20) 21) Chlamydia pneumoniae22) and Mycoplasma pneumoniae.23) TLR2 also protects from intracellular infections such as Mycobacteria tuberculosis.24)

Antimicrobial peptides

The antimicrobial peptides (AMPs), of which there are hundreds, are families of proteins, which have been called “the body's natural antibiotics,” crucial for both prevention and clearance of infection. AMPs are broad-spectrum, responding to pathogens in a non-specific manner.25)

For example, consider cathelicidin, a protein transcribed by the VDR, which not unlike a Swiss Army knife, has many different functions. Because it can be differentially spliced, the cathelicidin protein itself can respond to a range of very different microbial challenges. In humans, the cathelicidin antimicrobial peptide gene encodes an inactive precursor protein (hCAP18) that is processed to release a 37amino-acid peptide (LL-37) from the C-terminus. LL-37 is susceptible to proteolitic processing by a variety of enzymes, generating many different cathelicidin-derived peptides, each of which has specific targets. For example, LL-37 is generated in response to Staphylococcus aureus, yet LL-37 represents 20% of the cathelicidin-derived peptides, with the smaller peptides being much more abundant and able to target even more diverse microbial forms.26)

AMPs have been documented to kill bacteria and disrupt their function through the following modes of action:

  • interfering with metabolism
  • targeting cytoplasmic components
  • disrupting membranes
  • act as chemokines and/or induce chemokine production, which directs traffic of bacteria

Also, AMPs aid in recovery from infection by:

  • promoting wound healing
  • inhibiting inflammation

In many cases, the exact mechanism by which antimicrobial peptides kill bacteria is unknown. In contrast to many conventional antibiotics including those used by the Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis., AMPs appear to be bacteriocidal (a killer of bacteria) instead of bacteriostatic (an inhibitor of bacterial growth).

Two of the more significant families of AMPs are cathelicidin and the beta-defensins. Of these two families, cathelicidin is the most common.

Cathelicidin is a “fire alarm”, generating protective NLRP3-dependent airway epithelial cell inflammatory responses 27)

The full extent by which microbes interfere with AMP expression is the subject of a rapidly growing body of research.28) 29) 30)

Recent research into valuable proteins

Whey proteins and numerous growth factors that regulate insulin secretion, differentiation of intestine epithelium cells, and also tissue restoration, are priceless in stimulation the immune system.

Lactoferrin shows the most comprehensive pro-health properties: antioxidative, anticancer, immune stimulative and even chemopreventive. Also peptides and amino acids formed from casein and whey proteins possess immune stimulative activity. The most valuable proteins, i.e. lactoferrin, immune globulins, lactoperoxidase and lisozyme, together with bioactive peptides, are resistant to pepsin and trypsin activity. This is why they maintain their exceptional biological activity. 31)

Antimicrobial peptides target fungi and viruses

The antimicrobial peptides play a role in mitigating the virulence of the virome and other non-bacterial infectious agents. In addition to its antibacterial activity, alpha-defensin human neutrophil peptide-1 inhibits HIV and influenza virus entry into target cells.32) It diminishes HIV replication and can inactivate cytomegalovirus, herpes simplex virus, vesicular stomatitis virus and adenovirus.33) In addition to killing both gram positive and gram-negative bacteria, human beta-defensins HBD-1, HDB-2, and HBD-3 have also been shown to kill the opportunistic yeast species Candida albicans.34) Cathelicidin also possesses antiviral and antifungal activity.35) 36)

In other words, there is a reason why this group of proteins are named antimicrobial peptides rather than antibacterial peptides.

Unexpected antimicrobial peptides

There are now several examples of substances believed to cause disease, which have since been proven to be part of host defense.

  • amyloid beta (amyloid-β) – In a seminal 2010 study, a team of Harvard researchers showed that amyloid beta – the hallmark of Alzheimer's disease – can act as an antimicrobial peptide, having antimicrobial activity against eight common microorganisms, including Streptococcus, Staphylococcus aureus, and Listeria.37) This led study author Rudolph E. Tanzi, PhD to conclude that amyloid beta is “the brain's protector.” However, a 2010 study suggests that toxic levels of amyloid beta “dramatically suppresses VDR expression.” This suggests that overexpression of amyloid beta serves the interests of at least some microbes.38) Read more.
  • certain human prion proteins

Evolutionarily conserved

The TLR2/1 and cathelicidin-vitamin D pathway has long played a “powerful force” in protecting the body against infection. This is evidenced by the fact that the Alu short interspersed element (SINE), which transcribes the vitamin D receptor binding element (VDRE), has been evolutionarily conserved for 55-60 million years, but not prior.39) The differences in this pathway between humans/primates and other mammals call into question animal models that try to emulate the vitamin D system and indeed the immune system.

Energy consumption

It has become clear in recent years that pretty much any immune cell in our body undergoes, upon its activation, a metabolic shift resembling the Warburg effect originally described for cancer cells. Immune cells increase glucose consumption and produce a significant portion of ATP by glycolysis ending with lactate even under oxygenated conditions; increased glycolysis is required for the generation of intermediate metabolites associated with the activation of the immune cell.

Increased energy consumption by immune cells requires a metabolic adaptation of the whole organism. During trauma or infection, the organism vitally depends on the immune system, which is therefore privileged in energy/nutrient allocation. According to Rainer Straub [2], insulin resistance caused by pro-inflammatory cytokines is a physiological way of the immune system to usurp energy/nutrients during acute stress from the rest of the organism because immune cells themselves do not become insulin resistant. 40)

Inflammation

Another component of the innate immune response is inflammation, the universal initial response of the organism to any injurious agent.41) Inflammation is a systemic physiological process fundamental for survival.42) The identification of bacteria and other pathogens triggers the release of inflammatory cytokines. These cytokines include interferon-gammaAn inflammatory cytokine which causes extra mast cells to differentiate to monocytes and then to further differentiate into macrophages and dendritic cells. These phagocytes are the most active cells of the immune system and are charged with digesting bacterial pathogens., tumor necrosis factor-alphaA cytokine critical for effective immune surveillance and is required for proper proliferation and function of immune cells. (TNF-alpha), and Nuclear Factor-kappa BA protein that stimulates the release of inflammatory cytokines in response to infection (NF-kappaBA protein that stimulates the release of inflammatory cytokines in response to infection). Cytokines are regulatory proteins, such as the interleukins and lymphokines, that are released by cells of the immune system and act as intercellular mediators in the generation of an immune response. The result is what medicine calls inflammation, which generally leads to an increase in symptoms.

Th1/Th17 inflammation

One key type of inflammation is the Th1/Th17 (T-helper) inflammatory response. In the interests of concision, the Th1/Th17, on this site and others, the Th1/Th17 response is referred to as the Th1 response. This reaction occurs in response to intracellular pathogens, which according to the Marshall Pathogenesis, play a driving force in chronic disease.

All Th1 diseases are marked by an inflammatory response

Before the Human Microbiome Project, scientists couldn't consistently link bacteria to inflammatory diseases. But with the advent of DNA sequencing technology, scientists have detected many of the bacteria capable of generating an inflammatory response. All diseases of unknown etiology are inflammatory diseases.

An inflammatory immune response—one of the body’s primary means to protect against infection—defines multiple established infectious causes of chronic diseases, including some cancers. Inflammation also drives many chronic conditions that are still classified as (noninfectious) autoimmune or immune-mediated (e.g., systemic lupus erythematosus, rheumatoid arthritis, Crohn’s disease). Both [the innate and adaptive immune systems] play critical roles in the pathogenesis of these inflammatory syndromes. Therefore, inflammation is a clear potential link between infectious agents and chronic diseases.

Siobhán M. O'Connor et al. 43)

Th2 inflammation

According to the Marshall Pathogenesis, generally speaking, any activity of the Th2 cytokines in chronic disease is a result of the primary Th1-inducing pathogens.

Many palliative therapies interfere with inflammation

While inflammation is associated with disease, inflammation often serves an invaluable role as the immune system fights off chronic pathogens. Numerous medications artificially suppress inflammation including anti-TNF drugsDrugs which interfere with the body's production of TNF-alpha - a cytokine necessary for recovery from infection, interferon, corticosteroids, antifungals, and anti-pyreutics. While interfering with the inflammatory response typically reduces immunopathologyA temporary increase in disease symptoms experienced by Marshall Protocol patients that results from the release of cytokines and endotoxins as disease-causing bacteria are killed. and makes a patient feel less symptomatic in the near term, doing so allows the bacteria which cause chronic disease to proliferate.

The release of cytokines appears to be essential for recovery after an infection. One study found that the cytokine TNF-alpha – which is blocked by anti-TNF drugs – is necessary for the proper expression of acquired specific resistance following infection with Mycobacterium tuberculosis.44) 45) 46) Another effect of the use of TNF blockers is to break or reduce the formation of granuloma, one of the body's mechanisms to control bacterial pathogens.47)

Commensal microbes

The host innate immune defense system is highly active in healthy tissue.48) Commensal bacteria can activate innate immune responses.49) 50)

Immune suppression

The surprising finding of science is that home and hospital environments can be less supportive of human health than the outdoors. exposure to environmental microbes helps protect against allergies and other inflammatory diseases 51) Exposure to environmental microbes helps protect against allergies and other inflammatory diseases

Environmental pollution, both visible and invisible, many palliative medications, and increasingly this century the cellular level radiation from wifi devices, are interfering with the capacity of the innate immune system to create the defensive molecules necessary to control intracellular infections

1)
Rasmussen SB, Reinert LS, Paludan SR. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS. 2009 May;117(5-6):323-37. doi: 10.1111/j.1600-0463.2009.02456.x.
[PMID: 19400860] [DOI: 10.1111/j.1600-0463.2009.02456.x]
2)
Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton S, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010 Oct;20(10):1352-60. doi: 10.1101/gr.107920.110. Epub 2010 Aug 24.
[PMID: 20736230] [PMCID: 2945184] [DOI: 10.1101/gr.107920.110]
3) , 15)
Wang T, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95. doi: 10.1210/me.2005-0106. Epub 2005 Jul 7.
[PMID: 16002434] [DOI: 10.1210/me.2005-0106]
4) , 25)
Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002 Jan 24;415(6870):389-95. doi: 10.1038/415389a.
[PMID: 11807545] [DOI: 10.1038/415389a]
5)
Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008 Aug;88(2):491S-499S. doi: 10.1093/ajcn/88.2.491S.
[PMID: 18689389] [DOI: 10.1093/ajcn/88.2.491S]
6)
Haskó G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 2004 Jan;25(1):33-9. doi: 10.1016/j.it.2003.11.003.
[PMID: 14698282] [DOI: 10.1016/j.it.2003.11.003]
7) , 51)
Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today. 1998 Mar;19(3):113-6. doi: 10.1016/s0167-5699(97)01204-8.
[PMID: 9540269] [DOI: 10.1016/s0167-5699(97)01204-8]
8)
Tsai S, Clemente-Casares X, Zhou AC, Lei H, Ahn JJ, Chan YT, Choi O, Luck H, Woo M, Dunn SE, Engleman EG, Watts TH, Winer S, Winer DA. Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection. Cell Metab. 2018 Dec 4;28(6):922-934.e4. doi: 10.1016/j.cmet.2018.08.003. Epub 2018 Aug 30.
[PMID: 30174303] [DOI: 10.1016/j.cmet.2018.08.003]
9)
Peixoto LG, Teixeira RR, Vilela DD, Barbosa LN, Caixeta DC, Deconte SR, de Assis de Araújo F, Sabino-Silva R, Espindola FS. Metformin attenuates the TLR4 inflammatory pathway in skeletal muscle of diabetic rats. Acta Diabetol. 2017 Oct;54(10):943-951. doi: 10.1007/s00592-017-1027-5. Epub 2017 Aug 9.
[PMID: 28791487] [DOI: 10.1007/s00592-017-1027-5]
10)
Ingels C, Vanhorebeek I, Van den Berghe G. Glucose homeostasis, nutrition and infections during critical illness. Clin Microbiol Infect. 2018 Jan;24(1):10-15. doi: 10.1016/j.cmi.2016.12.033. Epub 2017 Jan 7.
[PMID: 28082192] [DOI: 10.1016/j.cmi.2016.12.033]
11)
de Oliveira Bravo M, Carvalho JL, Saldanha-Araujo F. Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression. Purinergic Signal. 2016 Dec;12(4):595-609. doi: 10.1007/s11302-016-9529-0. Epub 2016 Aug 25.
[PMID: 27557887] [PMCID: 5124006] [DOI: 10.1007/s11302-016-9529-0]
12)
Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016 May 3;7(3):189-200. doi: 10.1080/19490976.2015.1134082. Epub 2016 Mar 10.
[PMID: 26963409] [PMCID: 4939913] [DOI: 10.1080/19490976.2015.1134082]
13)
Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there?. Nat Rev Drug Discov. 2006 Dec;5(12):993-6. doi: 10.1038/nrd2199.
[PMID: 17139284] [DOI: 10.1038/nrd2199]
14)
Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010 Nov;26(6):591-5. doi: 10.1097/MOG.0b013e32833d4b9f.
[PMID: 20639756] [PMCID: 2955835] [DOI: 10.1097/MOG.0b013e32833d4b9f]
16)
Li YC, Bolt MJ, Cao LP, Sitrin MD. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am J Physiol Endocrinol Metab. 2001 Sep;281(3):E558-64. doi: 10.1152/ajpendo.2001.281.3.E558.
[PMID: 11500311] [DOI: 10.1152/ajpendo.2001.281.3.E558]
17)
Wang T, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004 Sep 1;173(5):2909-12. doi: 10.4049/jimmunol.173.5.2909.
[PMID: 15322146] [DOI: 10.4049/jimmunol.173.5.2909]
18)
Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005 Jul;19(9):1067-77. doi: 10.1096/fj.04-3284com.
[PMID: 15985530] [DOI: 10.1096/fj.04-3284com]
19)
Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zügel U, Bikle DD, Modlin RL, Gallo RL. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007 Mar;117(3):803-11. doi: 10.1172/JCI30142. Epub 2007 Feb 8.
[PMID: 17290304] [PMCID: 1784003] [DOI: 10.1172/JCI30142]
20)
Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000 Nov 15;165(10):5392-6. doi: 10.4049/jimmunol.165.10.5392.
[PMID: 11067888] [DOI: 10.4049/jimmunol.165.10.5392]
21)
González-Zorn B, Senna JPM, Fiette L, Shorte S, Testard A, Chignard M, Courvalin P, Grillot-Courvalin C. Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect Immun. 2005 Mar;73(3):1847-51. doi: 10.1128/IAI.73.3.1847-1851.2005.
[PMID: 15731086] [PMCID: 1064969] [DOI: 10.1128/IAI.73.3.1847-1851.2005]
22)
Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI. Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun. 2007 Feb;75(2):753-9. doi: 10.1128/IAI.01386-06. Epub 2006 Dec 4.
[PMID: 17145941] [PMCID: 1828523] [DOI: 10.1128/IAI.01386-06]
23)
Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, Campbell K, Harbeck RJ, Martin RJ. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol. 2005 May 1;174(9):5713-9. doi: 10.4049/jimmunol.174.9.5713.
[PMID: 15843573] [DOI: 10.4049/jimmunol.174.9.5713]
24)
Carlos D, Frantz FG, Souza-Júnior DA, Jamur MC, Oliver C, Ramos SG, Quesniaux VF, Ryffel B, Silva CL, Bozza MT, Faccioli LH. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection. Microbes Infect. 2009 Jul-Aug;11(8-9):770-8. doi: 10.1016/j.micinf.2009.04.025. Epub 2009 May 13.
[PMID: 19442756] [DOI: 10.1016/j.micinf.2009.04.025]
26) , 33)
Auvynet C, Rosenstein Y. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J. 2009 Nov;276(22):6497-508. doi: 10.1111/j.1742-4658.2009.07360.x. Epub 2009 Oct 9.
[PMID: 19817855] [DOI: 10.1111/j.1742-4658.2009.07360.x]
27)
McHugh BJ, Wang R, Li H, Beaumont PE, Kells R, Stevens H, Young L, Rossi AG, Gray RD, Dorin JR, Gwyer Findlay EL, Brough D, Davidson DJ. Cathelicidin is a "fire alarm", generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosa. PLoS Pathog. 2019 Apr 12;15(4):e1007694. doi: 10.1371/journal.ppat.1007694. eCollection 2019 Apr.
[PMID: 30978238] [PMCID: 6481867] [DOI: 10.1371/journal.ppat.1007694]
28)
Chakraborty K, Ghosh S, Koley H, Mukhopadhyay AK, Ramamurthy T, Saha DR, Mukhopadhyay D, Roychowdhury S, Hamabata T, Takeda Y, Das S. Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol. 2008 Dec;10(12):2520-37. doi: 10.1111/j.1462-5822.2008.01227.x. Epub 2008 Aug 20.
[PMID: 18717821] [DOI: 10.1111/j.1462-5822.2008.01227.x]
29)
Apidianakis Y, Mindrinos MN, Xiao W, Lau GW, Baldini RL, Davis RW, Rahme LG. Profiling early infection responses: Pseudomonas aeruginosa eludes host defenses by suppressing antimicrobial peptide gene expression. Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2573-8. doi: 10.1073/pnas.0409588102. Epub 2005 Feb 4.
[PMID: 15695583] [PMCID: 549001] [DOI: 10.1073/pnas.0409588102]
30)
Bergman P, Johansson L, Asp V, Plant L, Gudmundsson GH, Jonsson A, Agerberth B. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol. 2005 Jul;7(7):1009-17. doi: 10.1111/j.1462-5822.2005.00530.x.
[PMID: 15953032] [DOI: 10.1111/j.1462-5822.2005.00530.x]
31)
Ambroziak A, Cichosz G. [Immune stimulative potency of milk proteins]. Pol Merkur Lekarski. 2014 Feb;36(212):133-6.
[PMID: 24720113]
32) , 34)
Krishnakumari V, Rangaraj N, Nagaraj R. Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob Agents Chemother. 2009 Jan;53(1):256-60. doi: 10.1128/AAC.00470-08. Epub 2008 Sep 22.
[PMID: 18809937] [PMCID: 2612179] [DOI: 10.1128/AAC.00470-08]
35)
Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T, Boguniewicz M, Leung DYM. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol. 2006 Apr;117(4):836-41. doi: 10.1016/j.jaci.2005.12.1345. Epub 2006 Feb 14.
[PMID: 16630942] [PMCID: 2727734] [DOI: 10.1016/j.jaci.2005.12.1345]
36)
Benincasa M, Scocchi M, Pacor S, Tossi A, Nobili D, Basaglia G, Busetti M, Gennaro R. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother. 2006 Nov;58(5):950-9. doi: 10.1093/jac/dkl382. Epub 2006 Oct 5.
[PMID: 17023499] [DOI: 10.1093/jac/dkl382]
37)
Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010 Mar 3;5(3):e9505. doi: 10.1371/journal.pone.0009505.
[PMID: 20209079] [PMCID: 2831066] [DOI: 10.1371/journal.pone.0009505]
38)
Dursun E, Gezen-Ak D, Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. J Alzheimers Dis. 2011;23(2):207-19. doi: 10.3233/JAD-2010-101377.
[PMID: 20966550] [DOI: 10.3233/JAD-2010-101377]
39)
Gombart AF, Saito T, Koeffler HP. Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics. 2009 Jul 16;10:321. doi: 10.1186/1471-2164-10-321.
[PMID: 19607716] [PMCID: 2716374] [DOI: 10.1186/1471-2164-10-321]
40)
Dolezal T. Adenosine: a selfish-immunity signal?. Oncotarget. 2015 Oct 20;6(32):32307-8. doi: 10.18632/oncotarget.4685.
[PMID: 26427038] [PMCID: 4741691] [DOI: 10.18632/oncotarget.4685]
41)
Eleftheriadis T, Antoniadi G, Liakopoulos V, Antoniadis N, Stefanidis I, Galaktidou G. Vitamin D receptor activators and response to injury in kidney diseases. J Nephrol. 2010 Sep-Oct;23(5):514-24.
[PMID: 20540037]
42)
Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, Rizzo C, Colonna-Romano G, Lio D, Di Carlo D, Palmas MG, Scurti M, Pini E, Franceschi C, Vasto S. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des. 2010;16(6):609-18. doi: 10.2174/138161210790883840.
[PMID: 20388071] [DOI: 10.2174/138161210790883840]
43)
O'Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerg Infect Dis. 2006 Jul;12(7):1051-7. doi: 10.3201/eid1207.060037.
[PMID: 16836820] [PMCID: 3291059] [DOI: 10.3201/eid1207.060037]
44)
Allie N, Alexopoulou L, Quesniaux VJF, Fick L, Kranidioti K, Kollias G, Ryffel B, Jacobs M. Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection. Immunology. 2008 Dec;125(4):522-34. doi: 10.1111/j.1365-2567.2008.02865.x. Epub 2008 Jun 9.
[PMID: 18544042] [PMCID: 2612548] [DOI: 10.1111/j.1365-2567.2008.02865.x]
45)
Arend SM, Breedveld FC, van Dissel JT. TNF-alpha blockade and tuberculosis: better look before you leap. Neth J Med. 2003 Apr;61(4):111-9.
[PMID: 12852719]
46)
Islam N, Kanost AR, Teixeira L, Johnson J, Hejal R, Aung H, Wilkinson RJ, Hirsch CS, Toossi Z. Role of cellular activation and tumor necrosis factor-alpha in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophages. J Infect Dis. 2004 Jul 15;190(2):341-51. doi: 10.1086/421522. Epub 2004 Jun 18.
[PMID: 15216471] [DOI: 10.1086/421522]
47)
Hamilton CD. Immunosuppression related to collagen-vascular disease or its treatment. Proc Am Thorac Soc. 2005;2(5):456-60. doi: 10.1513/pats.200508-091JS.
[PMID: 16322600] [PMCID: 2713334] [DOI: 10.1513/pats.200508-091JS]
48)
Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010 Jul;8(7):481-90. doi: 10.1038/nrmicro2337.
[PMID: 20514045] [DOI: 10.1038/nrmicro2337]
49)
O'Neill LAJ. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev. 2008 Dec;226:10-8. doi: 10.1111/j.1600-065X.2008.00701.x.
[PMID: 19161412] [DOI: 10.1111/j.1600-065X.2008.00701.x]
50)
Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol. 2003 Oct;74(4):479-85. doi: 10.1189/jlb.0203082. Epub 2003 Jul 1.
[PMID: 12960260] [DOI: 10.1189/jlb.0203082]
home/pathogenesis/innate_immunity.txt · Last modified: by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.